UK-based medical cannabis cultivator Glass Pharms has announced the launch of a new range of own-branded ‘cannabis-based products for medicinal use’ (CBPMs).
Glass Pharms has now launched three products, which will be available in a number of UK pharmacies in the near future.
It comes just weeks after it became the first UK cultivator since medical cannabis was legalised in 2018 to deliver domestically grown product to patients.
While more own-branded products are said to be in the works, Glass Pharms assured Business of Cannabis that its focus remains on providing flower for third-party customers.
What happened?
Today, the Wiltshire-based company announced the launch of three new CBPMs to the market after working with an unnamed ‘UK pharmaceutical manufacturing partner’ to finalise the products.
These will consist of a high-CBD flower that contains less than 1% THC, and two high-THC strains at different price points.
One of the key drivers of this new venture was to enable Glass Pharms to bring new cultivars to market, especially its high-CBD offering.
According to a recent study published by the University of Colorado Boulder, its CBD-dominant ratio may be more effective in treating anxiety than higher THC strains.
Glass Pharms CEO, James Duckenfield, said: “As well as producing high-THC cannabis flower, we have a commitment to bring CBD-containing medical cannabis flower to the UK market as we believe it gives prescribers options for cannabis-naive patients that would otherwise be missing.
“Careful titration of THC content has been shown to improve the initial patient experience and led to better outcomes for new users of medical cannabis.”
Alongside this, Glass Pharms will be offering two high-THC strains. The first, described as an ‘interesting cultivar’ containing 17% THC and 2% CBG, will be at an ‘entry level’ price point.
The second will be a high-terpene, high-THC (20%) cultivar at a slightly higher price point.
While Glass Pharms did not specify where these new strains would be available to purchase, it said it was focusing on making them available in pharmacies rather than clinics.
More
https://businessofcannabis.com/glass-pharms-launches-own-branded-products-to-uk-market/
